Corrigendum to “Engineering prodrug nanoparticles for targeted therapy in heterogeneous glioblastoma” [Chem. Eng. J. 474 (2023) 145557]

IF 13.3 1区工程技术 Q1 ENGINEERING, CHEMICAL

Chemical Engineering Journal Pub Date : 2024-11-24 DOI:10.1016/j.cej.2024.157714

Xuefeng Zhang, Qing Guo, Zongren Zhao, Peng Cheng, Anhua Wu, Hongmei Liu

引用次数: 0

Abstract

The authors regret, 3.4. Therapeutic A-PER-p(TMZ)₂₉ combined PER with TMZ to promote antitumor effects in U87 and GSC22-bearing mice

查看原文本刊更多论文

对 "用于异质胶质母细胞瘤靶向治疗的原药纳米颗粒工程 "的更正 [Chem. Eng. J. 474 (2023) 145557]

作者感到遗憾的是，3.4.治疗性 A-PER-p(TMZ)29将 PER 与 TMZ 结合，促进 U87 和 GSC22 小鼠的抗肿瘤效果

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Chemical Engineering Journal 工程技术-工程：化工

CiteScore

21.70

自引率

9.30%

发文量

6781

审稿时长

2.4 months

期刊介绍： The Chemical Engineering Journal is an international research journal that invites contributions of original and novel fundamental research. It aims to provide an international platform for presenting original fundamental research, interpretative reviews, and discussions on new developments in chemical engineering. The journal welcomes papers that describe novel theory and its practical application, as well as those that demonstrate the transfer of techniques from other disciplines. It also welcomes reports on carefully conducted experimental work that is soundly interpreted. The main focus of the journal is on original and rigorous research results that have broad significance. The Catalysis section within the Chemical Engineering Journal focuses specifically on Experimental and Theoretical studies in the fields of heterogeneous catalysis, molecular catalysis, and biocatalysis. These studies have industrial impact on various sectors such as chemicals, energy, materials, foods, healthcare, and environmental protection.